Validation Report #029788

Share results:

Cutaneous lymphocyte-associated antigen (CLA) ELISA Kit (ABIN365957) has been independently validated for Enzyme-linked immunosorbent assay by the Science Exchange network of experts.

The Science Exchange network is used to independently validate research reagents, protocols, and results to ensure accuracy and reproducibility.

Validation number: #029788
Validated on: 08/12/14

Summary

Antigen

Cutaneous lymphocyte-associated antigen (CLA)

Catalog number
Supplier

Cusabio

Supplier catalog number
Lot number

X19184064

Method validated
Laboratory
Validation number
Positive Control

Human serum - expression is ~650 pg/mL

Negative Control

Goat serum (non-reactive species)

Notes

Target protein was detected in the positive control sample and not in the negative control sample as expected.

Independent Results

Full Methods

ELISA kit

  • Antigen: Cutaneous lymphocyte-associated antigen (CLA)
  • Catalog number: ABIN365957
  • Supplier: Cusabio
  • Supplier catalog number: csb-e09125h
  • Lot number: X19184064

Controls

  • Positive control: Human serum (Sigma Aldrich, Cat# H6914-20ML, Lot# SLBK2170V)
  • Negative control: Goat serum (Sigma Aldrich, Cat# G9023-10ML, Lot# SLBH2670V)

Protocol

  1. All reagents were brought up to room temperature for 30 minutes prior to use. The 1x Wash Buffer was prepared by adding 20 mL of 25x Wash Buffer Concentrate to 480 mL of distilled/deionized water and mixing thoroughly.
  2. The vial of Standard was reconstituted with 1 mL of Sample Diluent, mixed, and allowed to sit for 15 minutes with gentle agitation.
  3. The standard curve was prepared by creating a 2-fold dilution series of seven standards (including the original undiluted vial) using Sample Diluent. Sample Diluent alone served as the 0 pg/mL standard.
  4. The assay plate was removed from the foil pouch and 100 μL of each standard and sample were added to the appropriate wells, in triplicate. The plate was covered with the adhesive strip provided and incubated for 2 hours at 37 °C.
  5. Approximately 10 minutes before the incubation ended, a 1x Biotin-antibody solution was prepared by diluting 60 μL of 100x Biotin-antibody into 5940 μL of Biotin-antibody Diluent.
  6. The liquid from each well was removed.
  7. 100 μL of 1x Biotin-antibody solution was added to each well, and the plate was covered with a new adhesive strip, and incubated for 1 hour at 37 °C.
  8. Approximately 10 minutes before the incubation ended, a 1x HRP-avidin solution was prepared by diluting 60 μL of 100x HRP-avidin into 5940 μL of HRP-avidin Diluent.
  9. Each well was aspirated and washed, repeating the process two times for a total of three washes. Each well was washed by filling each well with 1x Wash Buffer and letting it stand for 2 minutes. After the last wash, remaining Wash Buffer was removed and the plate was inverted and blotted against clean, absorbent paper towels.
  10. 100 μL of 1x HRP-avidin solution was added to each well, the plate was covered with a new adhesive strip, and incubated for 1 hour at 37 °C.
  11. The aspiration/wash procedure from Step 9 was repeated for an additional 5 washes.
  12. 90 μL of TMB Substrate was added to each well. The plate was protected from light and incubated for 15-30 minutes at 37 °C, with periodic checking to prevent overdevelopment.
  13. 50 μL of Stop Solution was added to each well and mixed thoroughly. The optical density (OD) of each well was measured within 5 minutes using a microplate reader set to 450 nm.
  14. A standard curve was generated by plotting the OD value for each standard on the y-axis against the concentration on the x-axis. A line of best fit through the points on the graph was used to generate an equation to calculate CLA concentrations of the samples based on their average OD values.

Experimental Notes

Well B1 was excluded from this dataset due to possible contamination. Other than that, there were no experimental challenges noted.

Figures

1407874054318 a3f31c9c366cfd03c2946c90a6a66bf4.png?fit=fill&mark=%2freproducibility%2ftsen logo
Figure 1: CLA standard curve graph and equation.
1407874054331 78cd51b600b05b7e8c820ad58e8ee612.png?fit=fill&mark=%2freproducibility%2ftsen logo
Figure 2: Plate layout. Standard concentrations are in pg/mL; serum dilution values indicate their fold change from the undiluted stock. Note that well B1 was excluded from this dataset due to possible contamination.
1407874054336 411e7380d54416db138e27958c4310da.png?fit=fill&mark=%2freproducibility%2ftsen logo
Figure 3: Raw OD readings of standards and controls. Note that well B1 was excluded from this dataset due to possible contamination.
1407874054338 5b240ce97040f3fa0e21d293d5980e78.png?fit=fill&mark=%2freproducibility%2ftsen logo
Figure 4: CLA concentrations calculated from standard curve formula. Upper panel = uncorrected for dilution; lower panel = corrected for dilution. On average, 3013 pg/mL of CLA was detected in the positive control (human serum) and 0 pg/mL of CLA was detected in the negative control (goat serum).
Validation badge

Learn more about our validation initiative.